PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹1,418 Cr | ₹1,171 Cr | ₹628 Cr | ₹950 Cr | ₹1,428 Cr |
What is the latest Operating Profit of PIRAMAL PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹1,418 Cr |
| Mar2024 | ₹1,171 Cr |
| Mar2023 | ₹628 Cr |
| Mar2022 | ₹950 Cr |
| Mar2021 | ₹1,428 Cr |
How is Operating Profit of PIRAMAL PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,418 Cr | 21.13 | |
| Mar2024 | ₹1,171 Cr | 86.32 | |
| Mar2023 | ₹628 Cr | -33.85 | |
| Mar2022 | ₹950 Cr | -33.50 | |
| Mar2021 | ₹1,428 Cr | - | |
Compare Operating Profit of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,991.6 Cr | 11.2% | 19.7% | -25.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 11.2% |
19.7% |
-25.8% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses